The IPO Buzz: Contineum Therapeutics’ IPO Jump-Starts April Market
April got underway for the IPO market early today – Monday, April 1, 2024 – with the launch of Phase I biotech Contineum Therapeutics (CTNM Proposed). The San Diego-based biotech, which is developing drugs to treat progressive MS (multiple sclerosis) and IPF (idiopathic pulmonary fibrosis), plans to price its $149.6 million IPO later this week to […]
April 1, 2024 Read More